TD Cowen Downgrades Edwards Lifesciences to Hold, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
TD Cowen has downgraded Edwards Lifesciences (NYSE:EW) from Buy to Hold and lowered the price target from $100 to $70.
July 25, 2024 | 7:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TD Cowen has downgraded Edwards Lifesciences from Buy to Hold and reduced the price target from $100 to $70, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold and the significant reduction in the price target from $100 to $70 by TD Cowen suggests a less favorable view on Edwards Lifesciences' future performance. This is likely to negatively impact the stock price in the short term as investors react to the revised outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100